Article
Enzyme replacement therapy for Gaucher disease
19 Nov 2008
Abstract excerpt
Gaucher disease is the most common lysosomal storage disease, and the first lysosomal storage disease for which a specific therapy has been developed. Enzyme replacement therapy, with glucocerebrosidase purified from human placentae, was introduced in 1991. Recombinant human glucocerebrosidase, produced by Chinese hamster ovary cells in tissue culture, became available in 1994 and has replaced the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
